Progressive autologous graft-versus-host disease induced by cyclosporin A

Julio Barredo, U. Yusuf, A. Hahn, M. R. Abboud, J. Laver

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The development of graft-versus-host disease (GVHD) in patients undergoing allogeneic bone marrow transplantation for leukemias and lymphomas has been associated with a lower incidence of relapse. This phenomenen is thought to be secondary to the anti-tumor effect of adoptively transferred cells. Cyclosporin A (CsA) therapy is known to cause autologous and syngeneic GVHD in experimental models and humans, and has been used in patients undergoing autologous bone marrow transplantation. It has been the consensus to date that CsA-induced autologous GVHD is generally mild, confined to the skin, self-limiting and non-life-threatening. We report a case of severe and progressive GVHD induced by CsA in a child following autologous bone marrow transplantation for acute lymphoblastic leukemia in second remission.

Original languageEnglish
Pages (from-to)659-662
Number of pages4
JournalBone Marrow Transplantation
Volume18
Issue number3
StatePublished - Sep 1 1996
Externally publishedYes

Fingerprint

Graft vs Host Disease
Cyclosporine
Bone Marrow Transplantation
Autologous Transplantation
Homologous Transplantation
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Lymphoma
Leukemia
Theoretical Models
Recurrence
Skin
Incidence
Neoplasms
Therapeutics

Keywords

  • Bone marrow transplantation
  • Cyclosporin A
  • Graft-versus-host disease

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Barredo, J., Yusuf, U., Hahn, A., Abboud, M. R., & Laver, J. (1996). Progressive autologous graft-versus-host disease induced by cyclosporin A. Bone Marrow Transplantation, 18(3), 659-662.

Progressive autologous graft-versus-host disease induced by cyclosporin A. / Barredo, Julio; Yusuf, U.; Hahn, A.; Abboud, M. R.; Laver, J.

In: Bone Marrow Transplantation, Vol. 18, No. 3, 01.09.1996, p. 659-662.

Research output: Contribution to journalArticle

Barredo, J, Yusuf, U, Hahn, A, Abboud, MR & Laver, J 1996, 'Progressive autologous graft-versus-host disease induced by cyclosporin A', Bone Marrow Transplantation, vol. 18, no. 3, pp. 659-662.
Barredo, Julio ; Yusuf, U. ; Hahn, A. ; Abboud, M. R. ; Laver, J. / Progressive autologous graft-versus-host disease induced by cyclosporin A. In: Bone Marrow Transplantation. 1996 ; Vol. 18, No. 3. pp. 659-662.
@article{3007d608f80143bcb4ca3725ae9d2389,
title = "Progressive autologous graft-versus-host disease induced by cyclosporin A",
abstract = "The development of graft-versus-host disease (GVHD) in patients undergoing allogeneic bone marrow transplantation for leukemias and lymphomas has been associated with a lower incidence of relapse. This phenomenen is thought to be secondary to the anti-tumor effect of adoptively transferred cells. Cyclosporin A (CsA) therapy is known to cause autologous and syngeneic GVHD in experimental models and humans, and has been used in patients undergoing autologous bone marrow transplantation. It has been the consensus to date that CsA-induced autologous GVHD is generally mild, confined to the skin, self-limiting and non-life-threatening. We report a case of severe and progressive GVHD induced by CsA in a child following autologous bone marrow transplantation for acute lymphoblastic leukemia in second remission.",
keywords = "Bone marrow transplantation, Cyclosporin A, Graft-versus-host disease",
author = "Julio Barredo and U. Yusuf and A. Hahn and Abboud, {M. R.} and J. Laver",
year = "1996",
month = "9",
day = "1",
language = "English",
volume = "18",
pages = "659--662",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Progressive autologous graft-versus-host disease induced by cyclosporin A

AU - Barredo, Julio

AU - Yusuf, U.

AU - Hahn, A.

AU - Abboud, M. R.

AU - Laver, J.

PY - 1996/9/1

Y1 - 1996/9/1

N2 - The development of graft-versus-host disease (GVHD) in patients undergoing allogeneic bone marrow transplantation for leukemias and lymphomas has been associated with a lower incidence of relapse. This phenomenen is thought to be secondary to the anti-tumor effect of adoptively transferred cells. Cyclosporin A (CsA) therapy is known to cause autologous and syngeneic GVHD in experimental models and humans, and has been used in patients undergoing autologous bone marrow transplantation. It has been the consensus to date that CsA-induced autologous GVHD is generally mild, confined to the skin, self-limiting and non-life-threatening. We report a case of severe and progressive GVHD induced by CsA in a child following autologous bone marrow transplantation for acute lymphoblastic leukemia in second remission.

AB - The development of graft-versus-host disease (GVHD) in patients undergoing allogeneic bone marrow transplantation for leukemias and lymphomas has been associated with a lower incidence of relapse. This phenomenen is thought to be secondary to the anti-tumor effect of adoptively transferred cells. Cyclosporin A (CsA) therapy is known to cause autologous and syngeneic GVHD in experimental models and humans, and has been used in patients undergoing autologous bone marrow transplantation. It has been the consensus to date that CsA-induced autologous GVHD is generally mild, confined to the skin, self-limiting and non-life-threatening. We report a case of severe and progressive GVHD induced by CsA in a child following autologous bone marrow transplantation for acute lymphoblastic leukemia in second remission.

KW - Bone marrow transplantation

KW - Cyclosporin A

KW - Graft-versus-host disease

UR - http://www.scopus.com/inward/record.url?scp=0029839340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029839340&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 659

EP - 662

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 3

ER -